Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated with new dates and a helpful links section, while some outdated dates and a previous revision note have been removed.SummaryDifference0.9%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest expected in July 2025, with new details on study duration, disability assessments, and cognitive function tests. Additionally, the reporting dates for results have been clarified.SummaryDifference38%
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check36 days agoChange DetectedThe page has been updated to reflect the submission of results, and the revision number has changed from v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check50 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.